Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Completed

Phase 1 Results N/A

Summary of Purpose

This is a Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation in depressed human subjects study.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 April 2014.

1 May 2012 25 Jan 2012 1 Feb 2014 1 Feb 2014 1 Nov 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Pharmacokinetics/Dynamics Study
  • Intervention: Parallel Assignment

Contacts

  • Lev G. Gertsik, MD

    888-228-7425